D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
IMVT holding history
Immunovant, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IMVT overviewAll 13F holders of IMVTFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,240,654
- Value
- $47.8M
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,240,654 | $47.8M | <0.1% | +1,240,654 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −56,700−100.0% | Sold out | Holders |
| Q3 2025 | 56,700 | $914.0K | <0.1% | −3,118−5.2% | Reduced | Holders |
| Q2 2025 | 59,818 | $957.1K | <0.1% | +9,284+18.4% | Added | Holders |
| Q1 2025 | 50,534 | $863.6K | <0.1% | −17,135−25.3% | Reduced | Holders |
| Q4 2024 | 67,669 | $1.68M | <0.1% | +5,234+8.4% | Added | Holders |
| Q3 2024 | 62,435 | $1.78M | <0.1% | +20,956+50.5% | Added | Holders |
| Q2 2024 | 41,479 | $1.10M | <0.1% | −14,435−25.8% | Reduced | Holders |
| Q1 2024 | 55,914 | $1.81M | <0.1% | −52−0.1% | Reduced | Holders |
| Q4 2023 | 55,966 | $2.36M | <0.1% | −86,598−60.7% | Reduced | Holders |
| Q3 2023 | 142,564 | $5.47M | <0.1% | −620,647−81.3% | Reduced | Holders |
| Q2 2023 | 763,211 | $14.5M | <0.1% | +318,758+71.7% | Added | Holders |
| Q1 2023 | 444,453 | $6.89M | <0.1% | +145,983+48.9% | Added | Holders |
| Q4 2022 | 298,470 | $5.30M | <0.1% | +298,470 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −20,371−100.0% | Sold out | Holders |
| Q4 2021 | 20,371 | $174.0K | <0.1% | +20,371 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −25,119−100.0% | Sold out | Holders |
| Q1 2021 | 25,119 | $403.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.